PET Imaging of Chronic Pain Syndromes



Status:Enrolling by invitation
Conditions:Psychiatric
Therapuetic Areas:Psychiatry / Psychology
Healthy:No
Age Range:18 - Any
Updated:1/19/2018
Start Date:June 7, 2017
End Date:June 6, 2020

Use our guide to learn which trials are right for you!

Central nervous system (CNS) changes associated with pain have been difficult to measure
until the development of functional neuroimaging techniques such as positron emission
tomography (PET). We have previously observed asymmetry in the thalamus associated with
chronic pain that altered during acupuncture therapy. Imaging studies of therapeutic
techniques for chronic pain in animals and humans have been quite limited. This study will be
the first to utilize FDG PET-MRI imaging of both the brain and body in order to assess CNS
changes and peripheral body changes related to chronic pain and its potential management.

The proposed study is based on our growing understanding of chronic pain and our ability to
use functional brain imaging to study in vivo neurophysiologic processes. It is important to
understand the brain and body mechanisms of chronic pain in order to better determine
therapeutic interventions to reduce pain. Part of the difficulty in treating chronic pain is
to determine how better to diagnose what specific issues are affecting the brain and body
that result in chronic pain. Participants will undergo a small battery of diagnostic tests
that include magnetic resonance imaging (MRI), positron emission tomography (PET). A
secondary goal of this study is to determine if undergoing chiropractic care alters body or
brain physiology in patients with chronic pain.

Inclusion Criteria for Chronic Pain Patients:

- Age greater than 18 years old.

- Have chronic pain symptoms for >3 months;

- Have moderate pain (>3/10) in 2 or more areas for more than 5 out of 7 days

- Is planning on undergoing chiropractic care for the clinical management of the chronic
pain.

- May be on pain medications provided that they are on a stable dose for at least 1
month

- Patients have no other pre-existing and active significant medical, neurological, or
psychological disorders.

- Minor, stable health problems that should have no substantial effect on cerebral blood
flow will be allowed (i.e. controlled hypertension, medication controlled diabetes).

- Patients will be allowed to be taking medications or supplements at the initial
intake, but they must be on a stable dose regimen for at least 1 month.

- Able to give informed consent and willing to complete the study at Thomas Jefferson
University and Marcus Institute of Integrative Health.

Inclusion Criteria for Healthy Controls:

- No significant current active medical conditions.

- Stable medical conditions as determined by the PI are allowed.

- No brain or body abnormalities that would affect the acquisition or analysis of the
scan.

Exclusion Criteria for Chronic Pain Patients and Healthy Controls:

- Pregnant or breast feeding

- Enrollment in active clinical trial/ experimental therapy within the prior 30 days.

- Subject is unable or unwilling to lie still in the scanner (i.e. due to claustrophobia
or weight)

- Subject has metal in their body or other reason that they cannot undergo magnetic
resonance imaging.
We found this trial at
2
sites
925 Chestnut Street
Philadelphia, Pennsylvania 19107
Principal Investigator: Andrew B. Newberg, MD
Phone: 215-503-3423
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
789 Lancaster Avenue
Villanova, Pennsylvania 19085
Principal Investigator: Andrew B. Newberg, MD
Phone: 215-503-3423
?
mi
from
Villanova, PA
Click here to add this to my saved trials